Grünenthal Announces New Chief Commercial Officer
Aachen, Germany – Grünenthal, a global leader in pain management and related diseases, has announced the appointment of Jan Adams, M.D. as their new Chief Commercial Officer (CCO) effective October 1, 2024. Adams, currently the Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will now take on the role of CCO, succeeding Janneke van der Kamp who will be leaving the company to pursue an opportunity outside Grünenthal.
Adams brings over twenty years of experience in the pharmaceutical and healthcare industry to his new role. Since joining Grünenthal in 2017, he has played a crucial role in the company’s transformational journey. As CSO, Adams led the development of a state-of-the-art research and development (R&D) organization, redefined the company’s R&D strategy, and built an industry-leading pipeline focused on delivering innovative treatments for acute and chronic pain. Prior to this, he served as Head of Strategy and Portfolio, where he played a key role in successful M&A projects and Grünenthal’s expansion into the U.S. market. Adams began his career as a resident in cardiology and holds a Medical Doctor degree. He is married with two children.
In his new role as CCO, Adams will be responsible for driving Grünenthal’s commercial strategy and operations. This includes overseeing the company’s global sales and marketing efforts, as well as identifying and pursuing new business opportunities.
Florian Dieckmann, Head of Global Corporate Affairs & Communication at Grünenthal, expressed his confidence in Adams’ ability to succeed in his new role. “We are excited to have Jan Adams take on the role of Chief Commercial Officer. His extensive experience and proven track record make him the perfect candidate to lead our commercial efforts and continue driving Grünenthal’s growth.”
Grünenthal, headquartered in Aachen, Germany, is dedicated to changing lives for the better through innovation in pain management and related diseases. With affiliates in 27 countries and products available in approximately 100 countries, Grünenthal’s impact is felt worldwide. In 2023, the company employed around 4,400 people and achieved revenues of €1.8 billion.
For more information about Grünenthal, please visit https://www.grunenthal.com. Follow them on LinkedIn at Grunenthal Group and on Instagram at grunenthal.
For media inquiries, please contact Florian Dieckmann, Head of Global Corporate Affairs & Communication, at +49 241 569-2555 or florian.dieckmann@grunenthal.com.
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.